Israel’s business newspaper Globes is reporting that medical device company Polyheal Ltd. has “reported satisfactory results in its first clinical trial. The company tested its sterile disposable suspension on 20 patients and successfully treated chronic wounds that did not respond to other products. It is currently conducting an evaluation trial to compare its technology with the best treatments currently available, with the aim of highlighting the advantages of its own product.”
The company’s wound treatment product Polyheal 1® is based on a proprietary chemically inert non-biodegradable microspheres, that are thought to promote wound healing. How they do that, no one seems to know for sure. The running theory is that the microspheres provide additional surface area for cell attachment. And this results in “a cascade of cellular events including changes in cell membrane, cytoskeletons, cytokines and altered gene regulation,” according to researchers at Rabin Medical Center.
Here’s what the company says about its product:
Polyheal’s wound healing technology is based on the concept of triggering the patient’s own cells to regenerate the deteriorated tissue of chronic wounds. This process of tissue repair is the core of Polyheal’s wound healing technology. The specially designed physical-chemical features of the microspheres were designed to optimize the therapeutic process.
The proprietary tissue repair technology is based on the use of non-biodegradable, chemically inert synthetic charged microspheres, characterized by their narrow size distribution.
The Company’s first product, consists of a water based suspension of microspheres, which can be easily applied onto the acute or chronic wound by direct wetting or by spraying. Polyheal’s findings show that its charged microspheres have a therapeutic effect on wound healing, by their activation of different types of cells in the wound space (inflammatory cells, fibroblasts and keratinocytes).
The company’s advanced chronic wound care and tissue repair product has been successfully tested in clinical trials for promoting the initiation of granulation tissue growth and remodeling of damaged skin tissue, when applied to the wound surface.
Our primary focus is clinical availability of advanced tissue repair treatments that bring improvements to health and quality of life for chronic wounds patients worldwide.
Polyheal collaborates with wound care specialists to develop innovative wound healing products with state-of-the-art clinical evidence and to support chronic wound patients with professional treatment guidelines.
Product page: The Advanced Microsphere-Based Wound Healing Technology…
